4//SEC Filing
Diffusion Pharmaceuticals Inc. 4
Accession 0001437749-16-032595
$CRVOCIK 0001053691operating
Filed
May 19, 8:00 PM ET
Accepted
May 20, 5:33 PM ET
Size
5.3 KB
Accession
0001437749-16-032595
Insider Transaction Report
Form 4
Kalergis David G
DirectorChairman and CEO
Transactions
- Award
Stock Option (Right to Buy)
2016-05-16+204,167→ 204,167 totalExercise: $0.96Exp: 2026-05-16→ Common Stock (204,167 underlying)
Footnotes (1)
- [F1]The shares underlying the options vest in equal parts each month until fully vested on the third anniversary of the grant date.
Documents
Issuer
Diffusion Pharmaceuticals Inc.
CIK 0001053691
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001053691
Filing Metadata
- Form type
- 4
- Filed
- May 19, 8:00 PM ET
- Accepted
- May 20, 5:33 PM ET
- Size
- 5.3 KB